Apr 15 |
Longeveron stock rallies 85% on Alzheimer's presentation (update)
|
Apr 15 |
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
|
Apr 15 |
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
|
Apr 13 |
Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)
|
Apr 11 |
Longeveron Announces Closing of $5.2 Million Public Offering
|
Apr 8 |
Gold Moves Higher; Auddia Shares Surge
|
Apr 8 |
Why Longeveron (LGVN) Stock Exploded Higher Today
|
Apr 8 |
Longeveron Announces Pricing of $5.25 Million Public Offering
|
Apr 8 |
Crude Oil Moves Lower; Perion Network Shares Tumble
|
Apr 8 |
Longeveron stock rallies 75% amid public offering, business update
|